DN Group AG Subsidiary Algene Achieves First Harvest of High-Purity Microalgae, Launching Series Production

Algene Holding SE, a subsidiary of DN Group AG, successfully harvested 4,500 liters of high-purity microalgae, marking the start of series production for use in cosmetics, food, and pharmaceuticals, with the first delivery imminent to a German cosmetics manufacturer.

Bay Area Metrowire Staff
Business
DN Group AG Subsidiary Algene Achieves First Harvest of High-Purity Microalgae, Launching Series Production

Algene Holding SE, a subsidiary of DN Group AG (ISIN: DE000A3DW408), announced the first harvest of high-purity microalgae, achieving a total yield of 4,500 liters. This milestone marks the beginning of series production for the microalgae raw material, which is intended for quality-critical products in the cosmetics and food industries, with potential applications in the pharmaceutical sector. The Algene platform, developed in cooperation with the Technical University of Munich, has successfully scaled up production.

Algene has entered extensive talks with well-known cosmetics companies for the purchase of the microalgae. The initial delivery to a leading German cosmetics manufacturer is planned for the coming days, with the biomass to be used primarily for laboratory tests and validation of active ingredients. This development underscores the growing market for algae as a strategic resource for food and bio-raw materials. According to the EU Commission, the European market for algae is projected to reach around 9 billion euros by 2030, highlighting the rapid growth and potential of this sector.

Ole Nixdorff, CEO of DN Group, commented: "For Algene, the start of series production is an important milestone. The market for microalgae is growing rapidly and offers enormous potential. The high level of interest underlines the high quality of the Algene material and the good market acceptance. As a shareholder in Algene, DN Group participates in this future market."

Algene Holding is positioning itself as an industrial platform for controlled microalgae production, addressing markets such as nutrition and food, cosmetics, life sciences, and aquaculture. The company's technology enables the production of high-purity microalgae, which are considered an important building block of the bioeconomy. The successful first harvest and imminent delivery to a major cosmetics manufacturer demonstrate the commercial viability and scalability of Algene's production process.

DN Group AG invests in impact companies with high growth opportunities in future industries such as AI, mobility, circular economy, food, health, and energy, supporting them in successful IPOs. The company is one of the leading providers of IPO and capital market transaction advice, connecting fast-growing ESG companies with international institutional investors. For more information, visit DN Group AG.

View the original release on NewMediaWire.

Blockchain Registration

QR Code for Blockchain Registration